Suppr超能文献

外源性钙调神经磷酸酶B的细胞摄取依赖于Toll样受体4/髓样分化蛋白2/CD14复合物,且钙调神经磷酸酶B是Toll样受体4的内源性配体。

Cellular uptake of exogenous calcineurin B is dependent on TLR4/MD2/CD14 complexes, and CnB is an endogenous ligand of TLR4.

作者信息

Yang Jinju, Qin Nannan, Zhang Hongwei, Yang Rui, Xiang Benqiong, Wei Qun

机构信息

Department of Biochemistry and Molecular Biology, Beijing Normal University, Gene Engineering and Biotechnology Beijing Key Laboratory, Beijing, 100875, P. R. of China.

出版信息

Sci Rep. 2016 Apr 19;6:24346. doi: 10.1038/srep24346.

Abstract

Our previous research showed that recombinant calcineurin B (rhCnB) stimulates cytokine secretion by immune cells, probably through TLR4. Exogenous CnB can be incorporated into many different tumour cells in vitro, but the mode of uptake and receptors required remain unknown. Here, we report that exogenous CnB is taken up by cells in a time- and concentration-dependent manner via clathrin-dependent receptor-mediated internalization. Our findings further confirm that uptake is mediated by the TLR4/MD2 complex together with the co-receptor CD14. The MST results revealed a high affinity between CnB and the TLR4 receptor complex. No binding was detected between CnB and LPS. CnB inhibited the uptake of LPS, and LPS also inhibited the uptake of CnB. These results indicate that the uptake of exogenous CnB did not occur through LPS and that CnB was not a chaperone of LPS. Thus, we conclude that TLR4 receptor complexes were required for the recognition and internalization of exogenous CnB. CnB could be a potential endogenous ligand of TLR4 and function as an agonist of TLR4. These properties of CnB support its potential for development as an anti-cancer drug.

摘要

我们之前的研究表明,重组钙调神经磷酸酶B(rhCnB)可能通过Toll样受体4(TLR4)刺激免疫细胞分泌细胞因子。外源性CnB在体外可被多种不同的肿瘤细胞摄取,但其摄取方式及所需受体仍不清楚。在此,我们报告外源性CnB通过网格蛋白依赖的受体介导的内吞作用以时间和浓度依赖的方式被细胞摄取。我们的研究结果进一步证实,摄取是由TLR4/MD2复合物与共受体CD14共同介导的。 MST结果显示CnB与TLR4受体复合物之间具有高亲和力。未检测到CnB与脂多糖(LPS)之间的结合。CnB抑制LPS的摄取,LPS也抑制CnB的摄取。这些结果表明外源性CnB的摄取不是通过LPS发生的,且CnB不是LPS的伴侣蛋白。因此,我们得出结论,TLR4受体复合物是外源性CnB识别和内化所必需的。CnB可能是TLR4的潜在内源性配体,并作为TLR4的激动剂发挥作用。CnB的这些特性支持其作为抗癌药物开发的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/065c/4835703/1f8671083e33/srep24346-f1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验